Consistent with these findings our data suggest that uNGAL levels are associated with worse outcomes in PAD patients and perhaps NGAL is released into circulation increasingly with worsening PAD status and subsequently cleared by kidney. The gene discussed is LCN2; the disease is peripheral arterial disease.